Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$211.32 USD
+6.07 (2.96%)
Updated May 13, 2024 04:00 PM ET
After-Market: $211.37 +0.05 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-7.38 | -2.93% |
Earnings Summary
For their last quarter, Madrigal Pharmaceuticals (MDGL) reported earnings of -$7.38 per share, missing the Zacks Consensus Estimate of -$6.06 per share. This reflects a negative earnings surprise of 21.78%. Look out for MDGL's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$7.38 per share, reflecting a year-over-year decrease of 57.36%.
Earnings History
Price & Consensus
Zacks News for MDGL
2 Top Biotech Buyout Candidates
MDGL: What are Zacks experts saying now?
Zacks Private Portfolio Services